indatraline has been researched along with alpha-synuclein in 1 studies
| Studies (indatraline) | Trials (indatraline) | Recent Studies (post-2010) (indatraline) | Studies (alpha-synuclein) | Trials (alpha-synuclein) | Recent Studies (post-2010) (alpha-synuclein) |
|---|---|---|---|---|---|
| 46 | 0 | 24 | 10,821 | 29 | 8,011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alarcón-Aris, D; Artigas, F; Bortolozzi, A; Campa, L; Cóppola-Segovia, V; Miquel-Rio, L; Montefeltro, A; Pavia-Collado, R; Paz, V; Revilla, R; Rodríguez-Aller, R; Ruiz-Bronchal, E; Torres-López, M | 1 |
1 other study(ies) available for indatraline and alpha-synuclein
| Article | Year |
|---|---|
Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
Topics: alpha-Synuclein; Amino Acid Substitution; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Glycoconjugates; Humans; Indans; Injections, Intraventricular; Locus Coeruleus; Male; Mesencephalon; Methylamines; Mice; Mice, Transgenic; Norepinephrine; Oligonucleotides, Antisense; Parkinson Disease; Pars Compacta; Point Mutation; Synaptic Transmission | 2021 |